Intrinsiqq
Embecta Corp. logo

Embecta Corp. Quality Score

EMBC

⊜ Compare
Quality37

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
100/100
4.4x

Under 20x, reasonable relative to earnings

Cash Flow Multiple
100/100
2.2x

Under 20x cash flow, well covered

Revenue Growth
0/100
-2.5%

Below 2%, essentially flat

Cash Flow Growth
0/100
-19.3%

Below 2%, essentially flat

Business Quality & Capital Allocation

Share Dilution
60/100
1.8%

Mild dilution under 2%

Margin Trend
0/100
-4.4pp

Contracted >2pp, margin pressure

Capital Structure
0/100
$1.29B

Net debt/FCF of 7.8x, high leverage

2022
$331M
$1.65B
2023
$327M
$1.66B
2024
$268M
$1.63B
2025
$226M
$1.45B
TTM
$215M
$1.50B
CashDebt
Return on Capital
60/100
13.8%

10–15%, respectable returns

Customize WeightsPremiumUpgrade

Embecta (EMBC) quality: score, margins and returns

Embecta (EMBC) scores 37/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 8 metrics each scored 0 to 100, on 23.0% operating margins and 13.8% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Embecta (EMBC) a high-quality business?+

Embecta scores 37 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a 23.0% operating margin and a 13.8% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Embecta's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from EMBC's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Embecta scores well and where it falls behind.

What is Embecta's return on invested capital (ROIC)?+

Embecta earns about 13.8% on its invested capital, which is solid. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to EMBC's margins and growth on this scorecard to judge durability.

How profitable is Embecta?+

Embecta runs an operating margin of about 23.0% and a net margin of about 8.6%. Revenue has grown at roughly -0.1% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 31 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 18 Sept 2026. How this is calculated.

Fiscal year ends Sep. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with EMBC

CompareIntrinsic value
TNDMTandem Diabetes Care Inc.
$19.05+7.93%26
INSPInspire Medical Systems, Inc.
$66.61+7.61%81
OFIXOrthofix Medical Inc.
$9.72+10.96%18
IRTCIrhythm Technologies Inc.
$134.00+6.04%45
ATECAlphatec Holdings Inc.
$8.28+10.84%45
NVCRNovoCure Ltd.
$14.61+8.79%24
HAEHaemonetics Corporation
$127.42+5.94%53
UFPTUFP Technologies Inc.
$329.82+17.66%40

Held by ETFs

EMBC is in 30 US ETFs. The largest of them, with EMBC's weight in each:

Spot a number that looks wrong? Check it in EMBC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing EMBC

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.